All News
Message to the Community - January 11, 2022
Tom Manion, NLH President and CEO, provides an update on a variety of topics, including community resiliency, COVID-19 testing and new Express Care services.
Message to the Community - December 10, 2021
Tom Manion, NLH President and CEO, provides an update on a variety of topics, including COVID-19 testing and vaccines and the current state of services at NLH.
Elisabeth B. Wilson, MD, joins D-HH and Dartmouth’s Geisel School of Medicine as new chair of the Department of Community and Family Medicine
Dr. Wilson has accepted the role as chair and professor of the Department of Community and Family Medicine for the D-HH system and Dartmouth’s Geisel School of Medicine. She begins her role in March 2022 and will succeed Cathleen Morrow, MD as chair.
New Vice Chair of Research for Obstetrics and Gynecology Named at Dartmouth-Hitchcock Health
D-HH has named Daisy Goodman, DNP, MPH, CARN-AP, APRN, CNM, as the vice chair of Research for Obstetrics and Gynecology (OB/GYN).
Dartmouth-Hitchcock Health Increases Minimum Wage to $17 per Hour
Responding to labor shortage, health system makes second major minimum wage adjustment in nine months
D-HH Launches Third Installment of its Virtual Roundtable Series as Effects of COVID-19 Pandemic Continue
“Heads Up: Coping Through COVID-19” is a pre-recorded series of virtual conversations featuring D-HH mental health experts, community partners and other experts offering information and tips for people of all ages
Message to the Community - September 2, 2021
Tom Manion, NLH President and CEO addresses the recent rise in emergency department and inpatient visits, the impact of staffing shortages and an update on Express Care.
D-HH Continues to Adapt to Rapidly Changing Health Care Landscape as COVID-19 Pandemic Rages On
National staffing crisis, pandemic resurgence have increased local impacts; health providers ask for understanding and patience as they make the best, difficult decisions to ensure excellent care
D-HH Answers Questions about Third COVID-19 Vaccine Dose for Immunocompromised People
The U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people, with the third dose to be administered at least 28 days following the first two doses.
CHaD Releases School Re-opening Guidance
As districts in New Hampshire and Vermont prepare to reopen schools for in-person learning in a few weeks, leadership from New Hampshire’s only children’s hospital, Children’s Hospital at Dartmouth-Hitchcock has released recommendations for schools.